Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01870609
Title Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Verastem, Inc.
Indications

malignant pleural mesothelioma

Therapies

Defactinib

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | CAN | BEL


No variant requirements are available.